CooperSurgical Adds to Its IVF Business

CooperSurgical Adds to Its IVF Business

CooperSurgical (NYSE: COO), a subsidiary of The Cooper Companies, Inc., has added another medical device maker focused on women’s health. This is CooperSurgical’s first acquisition in 2018, and it didn’t go far from its Trumbull, Connecticut offices to find The LifeGlobal Group in Guilford, Connecticut. LifeGlobal is a leading provider of in vitro fertilization (IVF) products and devices, with operating facilities in the United States, Canada, Europe, Hong Kong and distributors in some 90 countries worldwide. The acquisition is expected to strengthen CooperSurgical’s fertility media offering and thus improve its industry leading fertility business overall. The deal... Read More »
Deal(s) of the Week: Teva, Take Two

Deal(s) of the Week: Teva, Take Two

Debt has been a key deal driver this year, particularly in the hospital sector, where Community Health Systems (NYSE: CYH), Quorum Health Corporation (NYSE: QHC) and Tenet Healthcare (NYSE: THC) are shedding less desirable assets. Joining them now is generic drug maker Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), which is shouldering $35 billion of debt brought on by its $40.5 billion acquisition of Allergan’s (NYSE: AGN) line of generics, announced in July 2015. The company hasn’t announced an acquisition since September 2016. What a difference a year makes, as generic drug prices have been squeezed and the company has been selling off non-core assets to pay down its... Read More »